Reps. Doggett, O'Rourke Call on Senate Finance Committee to Hold HHS Secretary Nominee Accountable for Record of Prescription Drug Price Increases
January 08, 2018
January 08, 2018
WASHINGTON, Jan. 8 -- Rep. Lloyd Doggett, D-Texas, issued the following news release:
Today, Congressman Lloyd Doggett (TX-35) and Congressman Beto O'Rourke (TX-16) led a letter urging the Senate Finance Committee to scrutinize Department of Health and Human Services (HHS) Secretary nominee Alex Azar's record of overseeing prescription drug price increases at Eli Lilly and his former statements on the Affordable Care Act. During Mr. Azar's tenure as President of the c . . .
Today, Congressman Lloyd Doggett (TX-35) and Congressman Beto O'Rourke (TX-16) led a letter urging the Senate Finance Committee to scrutinize Department of Health and Human Services (HHS) Secretary nominee Alex Azar's record of overseeing prescription drug price increases at Eli Lilly and his former statements on the Affordable Care Act. During Mr. Azar's tenure as President of the c . . .